Cheng SL - Search Results

1

The Benefits of Molnupiravir Treatment in Healthcare Facilities Patients with COVID-19.

Cheng SL, Wang PH, Chang CY, Wang HH, Wang CJ, Chiu KM. Cheng SL, et al. Drug Des Devel Ther. 2023 Jan 19;17:87-92. doi: 10.2147/DDDT.S392708. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 36698540 Free PMC article. Clinical Trial.

2

Hoarseness in asthmatic patients: the side effect of inhaled steroid or not?

Wang PH, Wang HC, Cheng PW, Cheng SL, Tsai CC. Wang PH, et al. Among authors: cheng sl, cheng pw. J Asthma. 2007 Dec;44(10):823-6. doi: 10.1080/02770900701743788. J Asthma. 2007. PMID: 18097857

3

Early achievement and maintenance of stable asthma control using initially higher-dose inhaled corticosteroids as part of combination therapy: an open-label pilot study.

Cheng SL, Wang HC, Kuo SH. Cheng SL, et al. Drug Des Devel Ther. 2013 Jun 17;7:477-84. doi: 10.2147/DDDT.S44231. Print 2013. Drug Des Devel Ther. 2013. PMID: 23818758 Free PMC article. Clinical Trial.

4

Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.

Cheng SL, Su KC, Wang HC, Perng DW, Yang PC. Cheng SL, et al. Drug Des Devel Ther. 2014 May 28;8:601-7. doi: 10.2147/DDDT.S63100. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24920884 Free PMC article. Clinical Trial.

5

Selection of empirical antibiotics for health care-associated pneumonia via integration of pneumonia severity index and risk factors of drug-resistant pathogens.

Wang PH, Wang HC, Cheng SL, Chang HT, Laio CH. Wang PH, et al. Among authors: cheng sl. J Formos Med Assoc. 2016 May;115(5):356-63. doi: 10.1016/j.jfma.2015.03.009. Epub 2015 May 2. J Formos Med Assoc. 2016. PMID: 25944735 Free article.

6

A review of omalizumab for the management of severe asthma.

Lin CH, Cheng SL. Lin CH, et al. Among authors: cheng sl. Drug Des Devel Ther. 2016 Jul 26;10:2369-78. doi: 10.2147/DDDT.S112208. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27528798 Free PMC article. Review.

7

Mono- and poly-functional T cells in nontuberculous mycobacteria lung disease patients: Implications in analyzing risk of disease progression.

Shu CC, Wu LS, Wu MF, Lai HC, Wang PH, Cheng SL, Wang JY, Yu CJ. Shu CC, et al. Among authors: cheng sl. Cytokine. 2019 Aug;120:176-185. doi: 10.1016/j.cyto.2019.05.001. Epub 2019 May 12. Cytokine. 2019. PMID: 31085455

8

The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship.

Shu CC, Wei YF, Yeh YC, Lin HH, Chen CY, Wang PH, Cheng SL, Wang JY, Yu CJ. Shu CC, et al. Among authors: cheng sl. Respir Res. 2020 Feb 12;21(1):51. doi: 10.1186/s12931-020-1294-5. Respir Res. 2020. PMID: 32050967 Free PMC article.

9

Clinical course and risk factors of mortality in Mycobacterium avium complex lung disease without initial treatment.

Wang PH, Pan SW, Shu CC, Chen CY, Wei YF, Cheng SL, Wang HC, Yu CJ. Wang PH, et al. Among authors: cheng sl. Respir Med. 2020 Sep;171:106070. doi: 10.1016/j.rmed.2020.106070. Epub 2020 Jun 25. Respir Med. 2020. PMID: 32658834 Free article.

10

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β₂ Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study.

Cheng SL, Ho ML, Lai YF, Wang HC, Hsu JY, Liu SF, Huang MS, Lee CH, Lin CH, Hang LW, Liu YC, Yang KY, Wang JH. Cheng SL, et al. Drug Des Devel Ther. 2020 Dec 8;14:5441-5450. doi: 10.2147/DDDT.S266177. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33324041 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

344 results

Search Page